G. Chanas-sacre et al., A 295-kDA intermediate filament-associated protein in radial glia and developing muscle cells in vivo and in vitro, DEV DYNAM, 219(4), 2000, pp. 514-525
The RC2 antibody is frequently used to label mouse radial glial cells in al
l parts of the nervous system where neuronal migration occurs during embryo
nic and early postnatal life. The antigen recognized by this antibody still
needs to be identified. We have characterized further its localization in
vivo, its expression and subcellular localization in vitro, as well as its
molecular nature. Histologic investigations of whole mouse embryos reveal a
n equally intense expression of RC2 immunostaining in radial glial cells in
brain and spinal cord and in skeletal muscle. In glial cells cultures, the
RC2 antibody recognizes an epitope located on the glial cytoskeleton and i
dentified as an intermediate filament associated protein (IFAP) at the ultr
astructural level. RC2 immunostaining in those cells is strongly dependent
on the presence of a serum-derived activity. Serum-removal causes a decreas
e of the staining while adding serum back to the cells induces reexpression
of RC2 immunoreactivity, By Western blotting, we find that in intermediate
filament (IF) preparations obtained from cultured cerebellar glia, the RC2
antibody recognizes a 295-kDa protein whose expression is also dependent o
n the presence of serum in culture medium. In developing muscle cells, RC2
immunostaining is observed from the myoblast stage and disappears after com
plete myotube fusion, Both in vivo and in vitro, staining is first seen as
a loose capping around myoblasts nuclei and progressively concentrates into
Z-disks in association with the muscle IF protein desmin, The RC2 antibody
also recognizes a 295-kDa protein band in muscle tissue protein extracts.
Thus, the RC2 antibody recognizes a developmentally regulated cytoskeletal
protein that is expressed, like other previously identified IFAPs, by cells
of the glial and myogenic lineages and whose expression in vitro seems to
be controlled by a signaling mechanism known to modulate astroglial morphol
ogy, (C) 2000 Wiley-Liss, Inc.